Ardian Inc., a Menlo Park, Calif.-based developer of a medical device to treat congestive heart failure, has raised around $10.08 million in Series B-1 funding, according to a regulatory filing. Return backers include WS Investment Co. was joined by return backers Advanced Technology Ventures, Morgenthaler Ventures and St. Paul Venture Capital.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: